SLC12A3 and Gitelman syndrome: Inactivating mutations of NCC lead to Gitelman's syndrome with hypotension13, 14, whereas over-activation of NCC by mutations of its with-no-lysine (WNK) regulators results in Gordon syndrome, exhibiting hypertension15, 16.